medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2014, Número 3

<< Anterior Siguiente >>

Rev Invest Clin 2014; 66 (3)


Pronóstico de los pacientes críticamente enfermos con neoplasias hematológicas

Ñamendys-Silva SA, Rodríguez-Andoney JJ

Idioma: Español
Referencias bibliográficas: 44
Paginas: 274-281
Archivo PDF: 243.83 Kb.


FRAGMENTO

CASO CLÍNICO

Mujer de 48 años con antecedente de leucemia linfoide aguda pre-B de riesgo estándar diagnosticada en 2002, recibió quimioterapia, documentándose remisión completa en 2004.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Namendys-Silva SA, Silva-Medina MA, Vásquez-Barahona GM, et al. Application of a modified sequential organ failure assessment score to critically ill patients. Braz J Med Biol Res 2013; 46: 186-93.

  2. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.

  3. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Guidelines for intensive care unit admission discharge and triage. Crit Care Med 1999; 27: 633-8.

  4. Azoulay E, Soares M, Darmon M, Benoit D, Pastores S, Afessa B. Intensive care of the cancer patient: recent achievements and remaining challenges. Ann Intensive Care 2011; 1: 5.

  5. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42.

  6. O’Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2003; 348: 994-1004.

  7. Salazar R, Solá C, Maroto P, et al. Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 23: 27-33.

  8. Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis 2013; 56: 711-7.

  9. Cloutier RL. Neutropenic enterocolitis. Hematol Oncol Clin North Am 2010; 24: 577-84.

  10. Bow EJ, Meddings JB. Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia. Leukemia 2006; 20: 2087-92.

  11. Gorschlüter M, Mey U, Strehl J, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol 2005; 75: 1-13.

  12. Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis 2013; 56: 711-7.

  13. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 2011; 52: e56-e93.

  14. Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986; 57: 603-09.

  15. Machado NO. Neutropenic enterocolitis: A continuing medical and surgical challenge. N Am J Med Sci 2010; 2: 293-300.

  16. Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL. Characteristics and outcomes of cancer patients in European ICUs. Crit Care 2009; 13: R15.

  17. Namendys-Silva SA, Texcocano-Becerra J, Herrera-Gómez A. Prognostic factors in critically ill patients with solid tumours admitted to an oncological intensive care unit. Anaesth Intensive Care 2010; 38: 317-24.

  18. Namendys-Silva SA, González-Herrera MO, García-Guillén FJ, Texcocano-Becerra J, Herrera-Gómez A. Outcome of critically ill patients with hematological malignancies. Ann Hematol 2013; 92: 699-705.

  19. Merz TM, Schär P, Bühlmann M, et al. Resource use and outcome in critically ill patients with hematological malignancy: a retrospective cohort study. Crit Care 2008; 12: R75.

  20. Azoulay E, Mokart D, Pène F, et al. Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium—A Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique Study. J Clin Oncol 2013; 31: 2810-8.

  21. Mokart D, Lambert J, Schnell D, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013; 54: 1724-9.

  22. Lecuyer L, Chevret S, Thiery G, Darmon M, Schlemmer B, Azoulay E. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 2007; 35: 808-14.

  23. Thiéry G, Azoulay E, Darmon M, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 2005; 23: 4406-13.

  24. Soares M, Fontes F, Dantas J, et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care 2004; 8: R194-R203.

  25. Chang L, Horng CF, Huang YC, et al. Prognostic accuracy of Acute Physiology and Chronic Health Evaluation II scoÑamendys- Silva SA, et al. Pronóstico de los pacientes críticamente enfermos con neoplasias hematológicas. Rev Invest Clin 2014; 66 (3): 274-281 281 res in critically ill cancer patients. Am J Crit Care 2006; 15: 47-53.

  26. Kopterides P, Liberopoulos P, Ilias I, et al. General prognostic scores in outcome prediction for cancer patients admitted to the intensive care unit. Am J Crit Care 2011; 20: 56-66.

  27. Thakkar SG, Fu AZ, Sweetenham JW, et al. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Cancer 2008; 112: 2233-40.

  28. Park HY, Suh GY, Jeon K, et al. Outcome and prognostic factors of patients with acute leukemia admitted to the intensive care unit for septic shock. Leuk Lymphoma 2008; 49: 1929-34.

  29. Lamia B, Hellot MF, Girault C, et al. Changes in severity and organ failure scores as prognostic factors in oncohematological malignancy patients admitted to the ICU. Intensive Care Med 2006; 32: 1560-8.

  30. Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a lifethreatening complication. Crit Care Med 2003; 31: 104-12.

  31. Vandijck DM, Depuydt PO, Offner FC, et al. Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies. Intensive Care Med 2010; 36: 1744-50.

  32. Geerse DA, Span LF, Pinto-Sietsma SJ, van Mook WN. Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality. Eur J Intern Med 2011; 22: 57-61.

  33. Cornet AD, Issa AI, van de Loosdrecht AA, et al. Sequential organ failure predicts mortality of patients with a haematological malignancy needing intensive care. Eur J Haematol 2005; 74: 511-6.

  34. Azoulay E, Recher C, Alberti C, et al. Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 1999; 25: 1395-401.

  35. Regazzoni CJ, Irrazabal C, Luna CM, Poderoso JJ. Cancer patients with septic shock: mortality predictors and neutropenia. Support Care Cancer 2004; 12: 833-9.

  36. Legrand M, Max A, Peigne V, et al. Survival in neutropenic patients with severe sepsis or septic shock. Crit Care Med 2012; 40: 43-9.

  37. Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA. Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 2008; 12: R77.

  38. Pène F, Aubron C, Azoulay E, et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643-9.

  39. Gilbert C, Vasu TS, Baram M. Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2013; 19: 321-4.

  40. Vandijck DM, Benoit DD, Depuydt PO, et al. Decruyenaere JM. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med 2008; 34: 847-55.

  41. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33: 2488-93.

  42. Sprung CL, Geber D, Eidelman LA, et al. Evaluation of triage decisions for intensive care admission. Crit Care Med 1999; 27: 1073-9.

  43. Volkow P, Bautista E, de la Rosa M, et al. The response of the intensive care units during the influenza A H1N1 pandemic: the experience in Chiapas, Mexico. Sal Pub Mex 2011; 53: 345-53.

  44. Instituto Nacional de Estadística y Geografía. INEGI. Censo de Población y Vivienda 2010. Disponible en: http://www3 inegi.org. mx/Sistemas/temasV2/Default.aspx?s=est&c=17484




2020     |     www.medigraphic.com